What does VERSTRAETE CHRISTINE APOTHEEK do?

VERSTRAETE CHRISTINE APOTHEEK is a pharmacy in Destelbergen. Public Limited, started on 25 August 1986, 1 establishment.

What is the address of VERSTRAETE CHRISTINE APOTHEEK?

The registered office of VERSTRAETE CHRISTINE APOTHEEK is located at Dendermondesteenweg 76, 9070 Destelbergen.

Is VERSTRAETE CHRISTINE APOTHEEK still active?

Yes. According to the CBE (30 October 2026) VERSTRAETE CHRISTINE APOTHEEK is active, legal situation “Normale toestand”, started on 25 August 1986.

Is VERSTRAETE CHRISTINE APOTHEEK registered on Peppol?

Yes, VERSTRAETE CHRISTINE APOTHEEK is registered on the Peppol network with ID 0208:0429442061.

What is the enterprise number of VERSTRAETE CHRISTINE APOTHEEK?

The enterprise number of VERSTRAETE CHRISTINE APOTHEEK is BE0429442061.

When was VERSTRAETE CHRISTINE APOTHEEK founded?

VERSTRAETE CHRISTINE APOTHEEK was founded on 25 August 1986.

Who are the directors of VERSTRAETE CHRISTINE APOTHEEK?

According to the 2026 annual accounts, the directors of VERSTRAETE CHRISTINE APOTHEEK are: Vervec NV, Angelina Brille, Véronique Verstraete.

Is VERSTRAETE CHRISTINE APOTHEEK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 August 1986; 5 annual accounts filed, latest fiscal year 2026; 3 directors known from the annual account.

How much profit did VERSTRAETE CHRISTINE APOTHEEK make in 2026?

VERSTRAETE CHRISTINE APOTHEEK posted a profit after taxes of € 100,712 in financial year 2026.

What is the revenue of VERSTRAETE CHRISTINE APOTHEEK?

As a small company, VERSTRAETE CHRISTINE APOTHEEK is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 114,206.

How many employees does VERSTRAETE CHRISTINE APOTHEEK have?

According to the 2026 annual accounts, VERSTRAETE CHRISTINE APOTHEEK has 0 full-time equivalents (FTE).

VERSTRAETE CHRISTINE APOTHEEK (Public Limited)

Dossier VERSTRAETE CHRISTINE APOTHEEK, printed on 30 October 2026 from databakkes.be/en/0429442061/verstraete-christine-apotheek. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

VERSTRAETE CHRISTINE APOTHEEK from Destelbergen, company number BE0429442061, closed financial year 2026 with a result of € 100,712 after tax. For that financial year VERSTRAETE CHRISTINE APOTHEEK recorded a gross margin of € 114,206 and equity of € 288,502. Compared with financial year 2025, the result moved from € 94,781 to € 100,712. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 7, 2026.

What it is worth Growing

€ 288,502

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 100,712

▲ 6% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 339,257

▲ 5% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

99 % of the profit went to the shareholders, mostly to VERVEC (97 % of the shares). That is where the money ends up.

People and assets in 2026

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 5,123

▲ 26% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 95,247

▲ 9% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 58

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 75,664 Gross margin 2023: € 75,664 First fiscal year in the series	€ 100,021 Gross margin 2024: € 100,021 ▲ 32% vs 2023 (€ 75,664) Favourable step	€ 110,618 Gross margin 2025: € 110,618 ▲ 11% vs 2024 (€ 100,021) Favourable step	€ 114,206 Gross margin 2026: € 114,206 ▲ 3% vs 2025 (€ 110,618) Favourable step	▲ 3%
Profit after taxes	€ 53,042 Profit after taxes 2023: € 53,042 First fiscal year in the series	€ 75,010 Profit after taxes 2024: € 75,010 ▲ 41% vs 2023 (€ 53,042) Favourable step	€ 94,781 Profit after taxes 2025: € 94,781 ▲ 26% vs 2024 (€ 75,010) Favourable step	€ 100,712 Profit after taxes 2026: € 100,712 ▲ 6% vs 2025 (€ 94,781) Favourable step	▲ 6%
Equity	€ 285,000 Equity 2023: € 285,000 First fiscal year in the series	€ 287,010 Equity 2024: € 287,010 ▲ 1% vs 2023 (€ 285,000) Favourable step	€ 287,790 Equity 2025: € 287,790 Unchanged (€ 287,010) Favourable step	€ 288,502 Equity 2026: € 288,502 Unchanged (€ 287,790) Favourable step
Total debts	€ 340,464 Total debts 2023: € 340,464 First fiscal year in the series	€ 379,471 Total debts 2024: € 379,471 ▲ 11% vs 2023 (€ 340,464) Unfavourable step	€ 406,615 Total debts 2025: € 406,615 ▲ 7% vs 2024 (€ 379,471) Unfavourable step	€ 417,985 Total debts 2026: € 417,985 ▲ 3% vs 2025 (€ 406,615) Unfavourable step	▲ 3%
Cash	€ 306,743 Cash 2023: € 306,743 First fiscal year in the series	€ 327,338 Cash 2024: € 327,338 ▲ 7% vs 2023 (€ 306,743) Favourable step	€ 323,348 Cash 2025: € 323,348 ▼ 1% vs 2024 (€ 327,338) Unfavourable step	€ 339,257 Cash 2026: € 339,257 ▲ 5% vs 2025 (€ 323,348) Favourable step	▲ 5%
Retained profit	€ 222,500 Retained profit 2023: € 222,500 First fiscal year in the series	€ 224,510 Retained profit 2024: € 224,510 ▲ 1% vs 2023 (€ 222,500) Favourable step	€ 225,290 Retained profit 2025: € 225,290 Unchanged (€ 224,510) Favourable step	€ 226,002 Retained profit 2026: € 226,002 Unchanged (€ 225,290) Favourable step
Dividend	€ 50,000 Dividend 2023: € 50,000 First fiscal year in the series	€ 73,000 Dividend 2024: € 73,000 ▲ 46% vs 2023 (€ 50,000) Unchanged	€ 94,000 Dividend 2025: € 94,000 ▲ 29% vs 2024 (€ 73,000) Unchanged	€ 100,000 Dividend 2026: € 100,000 ▲ 6% vs 2025 (€ 94,000) Unchanged	▲ 6%
Balance sheet total	€ 625,464 Balance sheet total 2023: € 625,464 First fiscal year in the series	€ 666,481 Balance sheet total 2024: € 666,481 ▲ 7% vs 2023 (€ 625,464) Unchanged	€ 694,405 Balance sheet total 2025: € 694,405 ▲ 4% vs 2024 (€ 666,481) Unchanged	€ 706,487 Balance sheet total 2026: € 706,487 ▲ 2% vs 2025 (€ 694,405) Unchanged	▲ 2%

Key figures of VERSTRAETE CHRISTINE APOTHEEK, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to VERSTRAETE CHRISTINE APOTHEEK?

What happened at VERSTRAETE CHRISTINE APOTHEEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Vervec NV stepped down as director. NBB
2029 Angelina Brille stepped down as director. NBB
2029 Véronique Verstraete stepped down as director. NBB
Oct 7, 2026 New annual accounts for financial year 2026: profit of € 100,712 (▲ 6% vs 2025). Source: NBB ↗
2023 Vervec NV became a director. NBB
2023 Angelina Brille became a director. NBB
2023 Véronique Verstraete became a director. NBB
Oct 21, 1986 New establishment in Destelbergen. KBO

In short

From € 53,042 profit in 2023 to € 100,712 profit in 2026.

Paid € 1,335 in corporate taxes since 2023.

Best year ever: 2026, with € 100,712 profit.

Paid out € 317,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

VERVEC 97.3%

The stake of VERVEC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VERSTRAETE CHRISTINE APOTHEEK

The shares are held by VERVEC (97.3%).

Directors

According to the 2026 annual accounts

Vervec NV

Managing director · represented by Christine Verstraete

since 2023 · until 2029

Angelina Brille

Director

Also active at: Transport Albert Brille, Albert BRILLE, VERVEC, Brille Wevelgem Immo

since 2023 · until 2029

Véronique Verstraete

Director

Also active at: Transport Albert Brille, Albert BRILLE, VERVEC, Brille Wevelgem Immo, VEREVI

since 2023 · until 2029

Shareholders

VERVEC

97.3%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dendermondesteenweg 76

9070 Destelbergen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VERVEC same network

€ 149,008 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.442.061

VAT number

BE 0429.442.061

Registered office

Dendermondesteenweg 76, 9070 Destelbergen

Names & denominations

VERSTRAETE CHRISTINE APOTHEEK

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

25 August 1986

Peppol

Active · Active since 19 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

VERSTRAETE CHRISTINE APOTHEEK

Financials

What happened to VERSTRAETE CHRISTINE APOTHEEK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions